Anuh Pharma Limited (BOM:506260)
India
· Delayed Price · Currency is INR 77.84
+0.65 (0.84%)
At close: Mar 9, 2026
Anuh Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,801 | 7,459 | 12,308 | 3,990 | 4,307 | 4,525 | Upgrade
|
| Market Cap Growth | -7.66% | -39.39% | 208.46% | -7.36% | -4.82% | 54.95% | Upgrade
|
| Enterprise Value | 7,673 | 7,081 | 11,824 | 3,486 | 4,209 | 4,202 | Upgrade
|
| Last Close Price | 77.84 | 73.17 | 119.27 | 38.08 | 40.42 | 41.97 | Upgrade
|
| PE Ratio | 18.65 | 15.75 | 20.49 | 11.03 | 14.09 | 15.91 | Upgrade
|
| PS Ratio | 1.02 | 1.13 | 1.90 | 0.76 | 0.89 | 1.05 | Upgrade
|
| PB Ratio | 2.39 | 2.29 | 4.23 | 1.65 | 2.02 | 2.37 | Upgrade
|
| P/TBV Ratio | 2.39 | 2.29 | 4.23 | 1.66 | 2.02 | 2.38 | Upgrade
|
| P/FCF Ratio | - | 43.93 | 155.62 | 7.62 | 15.81 | - | Upgrade
|
| P/OCF Ratio | - | 20.09 | 95.22 | 7.40 | 14.92 | - | Upgrade
|
| EV/Sales Ratio | 1.00 | 1.07 | 1.83 | 0.66 | 0.87 | 0.97 | Upgrade
|
| EV/EBITDA Ratio | 13.22 | 11.21 | 15.78 | 6.56 | 8.74 | 9.54 | Upgrade
|
| EV/EBIT Ratio | 15.57 | 12.89 | 17.68 | 7.97 | 11.52 | 14.23 | Upgrade
|
| EV/FCF Ratio | - | 41.71 | 149.51 | 6.66 | 15.45 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.03 | 0.01 | 0.00 | 0.02 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.17 | 0.04 | 0.02 | 0.09 | 0.31 | Upgrade
|
| Debt / FCF Ratio | - | 0.64 | 0.34 | 0.02 | 0.16 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.19 | -0.20 | -0.22 | -0.10 | 0.00 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.22 | -0.99 | -0.79 | -0.98 | -0.44 | 0.01 | Upgrade
|
| Net Debt / FCF Ratio | - | -3.68 | -7.53 | -1.00 | -0.77 | -0.02 | Upgrade
|
| Asset Turnover | - | 1.39 | 1.52 | 1.40 | 1.43 | 1.31 | Upgrade
|
| Inventory Turnover | - | 6.76 | 6.64 | 5.34 | 4.72 | 4.66 | Upgrade
|
| Quick Ratio | - | 1.68 | 1.69 | 1.42 | 1.23 | 0.98 | Upgrade
|
| Current Ratio | - | 2.11 | 2.22 | 1.91 | 1.98 | 1.71 | Upgrade
|
| Return on Equity (ROE) | - | 15.34% | 22.56% | 15.90% | 15.11% | 16.12% | Upgrade
|
| Return on Assets (ROA) | - | 7.21% | 9.83% | 7.27% | 6.72% | 5.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.72% | 17.23% | 24.38% | 17.46% | 14.87% | 13.18% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 16.70% | 22.80% | 17.90% | 16.90% | 15.30% | Upgrade
|
| Earnings Yield | 5.36% | 6.35% | 4.88% | 9.07% | 7.10% | 6.28% | Upgrade
|
| FCF Yield | - | 2.28% | 0.64% | 13.12% | 6.33% | -5.50% | Upgrade
|
| Dividend Yield | 0.97% | 1.03% | 1.05% | 2.63% | 2.17% | 1.79% | Upgrade
|
| Payout Ratio | - | 26.45% | 16.69% | 24.18% | 24.73% | - | Upgrade
|
| Total Shareholder Return | 1.05% | 1.03% | 1.05% | 2.63% | 2.17% | 1.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.